WeVote
Log In

Bill

Bill

SB 351

Public health, authorized forms of single-dose epinephrine used by public schools and authorized entities expanded

2026 Regular Session Introduced by April Weaver

Alabama bill expands types of epinephrine auto-injectors schools can stock for emergency anaphylaxis treatment, improving medication access and potentially lowering costs.

Currently Indefinitely Postponed
#health
0
WeVote Research Nonpartisan
Bill Summary · SB 351

Legislative bill overview

SB 351 expands the types of single-dose epinephrine auto-injectors that public schools and authorized entities in Alabama are permitted to stock and use for emergency anaphylaxis treatment. Currently, Alabama law likely restricts schools to specific epinephrine formulations; this bill broadens those authorized forms to include additional products or delivery mechanisms approved for emergency use.

Why is this important

Anaphylaxis is a life-threatening allergic reaction requiring immediate epinephrine administration. Expanding authorized epinephrine forms could improve access to treatment by allowing schools to use newer formulations, generic alternatives, or products with different dosage options—potentially reducing costs and ensuring medication availability during emergencies when specific brands are unavailable.

Potential points of contention

  • Product standardization and training: Expanding authorized forms may require staff retraining if different auto-injectors have varying activation mechanisms or administration procedures, raising implementation and liability concerns
  • Cost implications: While generics could reduce expenses, some newer formulations may be more expensive, creating budget pressures for schools with limited resources
  • Regulatory clarity: The bill's language on which "authorized forms" qualify needs specificity; overly broad language could create confusion about what schools can actually stock and use

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.